...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Differences of Opinion
Reply New Message
Back To Forum List View
Icon president Differences of Opinion
5
SanFrancisco99
May 24, 2016 10:55AM
Re: Differences of Opinion
4
KayakerBC
May 24, 2016 11:48AM
Re: Differences of Opinion
4
KayakerBC
May 24, 2016 01:42PM
Re: Differences of Opinion

KayakerBC
May 24, 2016 02:55PM
Re: Differences of Opinion
8
fouremm
May 24, 2016 04:25PM
Re: Differences of Opinion
2
Jkj193741
May 24, 2016 06:59PM

JK,

I made a few comments regarding this paper on the RVX board. Also, keep in mind that the meeting abstracts describing the top-line data and results, as well as Resverlogix news releases regarding these data have been publicly available for some time now either at the conference websites or the Resverlogix website.

BearDownAZ

1 Recommendations
Re: Differences of Opinion
4
PVLee
May 24, 2016 11:43PM
Re: Differences of Opinion
1
Jkj193741
May 24, 2016 11:48PM
Icon president Re: Differences of Opinion
3
SanFrancisco99
May 25, 2016 12:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply